ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,827Medicare Part D Prescriptions Filled, Including Refills

Rank: 1024 out of 3593

$98.5K Total Retail Price of All Prescriptions

Rank: 2774 out of 3593

2,911 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 2,911 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 6,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$14 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

2 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AZITHROMYCIN 662 617 1 34
DICLOFENAC SODIUM 273 253 2 74
ROBAFEN-DM CLEAR 268 255 10 3 241
CIPROFLOXACIN HCL 252 242 4 52
LORATADINE 246 227 5 129
IBUPROFEN 220 201 6 43
MUPIROCIN 194 182 7 132
HYDROCODONE-ACETAMINOPHEN 193 170 S3 8 7
PHENAZOPYRIDINE HCL 161 150 10 9 350
MECLIZINE HCL 156 148 10 96
ONDANSETRON ODT 149 134 10 11 441
FAMOTIDINE 145 138 12 70
METHYLPREDNISOLONE 135 130 13 103
FLUTICASONE PROPIONATE 133 123 14 32
FUROSEMIDE 132 129 15 9
AMOX TR-POTASSIUM CLAVULANATE 125 114 16 138
LIDODERM 122 118 17 78
RANITIDINE HCL 107 102 18 27
LEVOFLOXACIN 107 102 18 116
HYDROMET 101 93 10 20 522
LOPERAMIDE 97 90 21 277
HYDROCHLOROTHIAZIDE 93 91 22 10
AMMONIUM LACTATE 92 88 23 125
FLUNISOLIDE 91 88 24 261
VOLTAREN 84 82 25 85
DOXYCYCLINE HYCLATE 75 70 26 141
LISINOPRIL 72 72 27 2
CLOTRIMAZOLE-BETAMETHASONE 64 63 28 94
GABAPENTIN 61 57 29 16
NAPROXEN 60 57 30 68
ALPRAZOLAM 60 55 30 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 55 32 102
OMEPRAZOLE 55 53 33 5
DIPHENHYDRAMINE HCL 55 54 R 33 286
ATENOLOL 52 52 35 11
ANTIPYRINE-BENZOCAINE 50 46 10 36 608
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.